Cognitive-behavioral (CBT) in ESRD Patients With Depression

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
Depression is common in end-stage renal disease (ESRD) patients and has a negative effect on the quality of life, functional ability, and mortality, with a prevalence rate as high as 20-25%. However, it is hard to use anti-depressant due to the safety issue, and there has been little data so far particularly in terms of randomized clinical trials. Here, we investigate the effect of cognitive-behavioral group therapy for enhancing mental health and quality of life in patients with ESRD.
Epistemonikos ID: 7056425089dc7a29df4d49eba3e62deb44d8e503
First added on: May 11, 2024